Subscribe to RSS
DOI: 10.1055/s-2002-32058
Familial Adenomatous Polyposis
Publication History
Publication Date:
06 June 2002 (online)

ABSTRACT
With 160,000 new cases diagnosed each year, colorectal carcinoma is the third most common malignancy in the United States. Twenty percent of all cases are secondary to an inherited genetic trait. Familial adenomatous polyposis (FAP) accounts for 1% of all colorectal cancers. Germline mutations in the adenomatous polyposis coli gene, mapped to chromosome 5q21, have been linked to this inherited form of colorectal cancer. Over 400 different mutations have been identified. Phenotypic expression of the disease is variable, ranging from an early-onset aggressive form to a late-onset attenuated variant. FAP has three notable forms. Gardner's syndrome is FAP associated with multiple soft tissue and bony abnormalities, ocular lesions, and upper gastrointestinal (GI) polyposis. Turcot's syndrome is adenomatous polyposis associated with central nervous system tumors. Attenuated FAP is a late onset disease (after 50 years of age). Patients with attenuated FAP have fewer polyps (fewer than 100) that are more proximal in location. Individuals diagnosed with FAP have a 100% lifetime risk of developing colorectal cancer. Moreover, they are at risk for duodenal and periampullary adenocarcinoma as well as desmoid tumors. Successful treatment of these patients depends upon early diagnosis. Therapeutic options include prophylactic colectomy with ileorectal anastomosis, total proctocolectomy with ileal pouch anal anastomosis reconstruction, or end ileostomy. Surveillance of the upper GI tract is necessary to evaluate for duodenal adenomatosis. Progressive adenomatosis, severe dysplasia in a polyp, or duodenal/periampullary adenocarcinoma are indications for surgical intervention. The development of polyposis registries, genetic testing, genetic counseling, and early screening colonoscopy are essential to early diagnosis and successful management of this disease.
KEYWORDS
Familial adenomatous polyposis - adenomatous polyposis coli - inherited colorectal cancer - Gardner's syndrome - Turcot's syndrome - attenuated familial adenomatous polyposis
REFERENCES
- 1 Greenlee R T, Murray T, Bolden S, Wingo P A. Cancer statistics, 2000. Cancer J Clin . 2000; 50 7-33
- 2 Rustgi A K. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med . 1994; 331 1694-1702
- 3 Winawer S J, Schottenfeld D, Flehinger B J. Colorectal cancer screening. J Natl Cancer Inst . 1991; 83 243-253
- 4 Burt R W. Colon cancer screening. Gastroenterology . 2000; 119 837-853
- 5 Kinzler K W, Vogelstein B. Lessons from hereditary colorectal cancer. Cell . 1996; 87 159-170
- 6 Wilmink A. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum . 1997; 40 483-493
- 7 Fearon E R, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell . 1990; 61 759-767
- 8 Vogelstein B, Fearon E R, Hamilton S R. Genetic alterations during colorectal tumor development. N Engl J Med . 1988; 319 525-532
- 9 Guillem J G, Smith A J, Culle J, Ruo L. Gastrointestinal polyposis syndromes. Curr Prob Surg . 1999; 36 219-323
- 10 Soravia C, Berk T, Cohen Z. Genetic testing and surgical decision making in hereditary colorectal cancer. In J Colorectal Dis . 2000; 15 21-28
- 11 Giardiello F M, Offerhaus J GA. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer . 1995; 31A 1085-1087
- 12 Bisgaard M L, Fenger K, Bulow S. Familial adenomatous polyposis (FAP): frequency, penetrance and mutation rate. Hum Mutat . 1994; 3 121-125
- 13 Distante S, Nasioulas S, Somers G R. Familial adenomatous polyposis in a 5 year old child: a clinical, pathological, and a molecular genetic study. J Med Genet . 1996; 33 157-160
- 14 Haggitt R C, Reid B J. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol . 1986; 10 871-887
- 15 Rustin R B, Jagelman D G, McGannon E. Spontaneous mutation in familial adenomatous polyposis. Dis Colon Rectum . 1990; 33 52-55
- 16 Herrera L, Kakati S, Gibas L. Brief clinical report: Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet . 1986; 25 473-476
- 17 Groden J, Thliveris A, Samowitz W. Identification and characterization of the familial adenomatous polyposis coli gene. Cell . 1991; 66 589-600
- 18 Kinzler K W, Nilbert M C, Su L K. Identification of FAP locus genes from chromosome 5q21. Science . 1991; 253 661-664
- 19 Leppert M, Dobbs M, Scambler P. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science . 1987; 238 1411-1413
- 20 O'Sullivan M J, McCarthy T V, Doyle C T. Familial adenomatous polyposis, from bedside to benchside. Am J Clin Pathol . 1998; 109 521-526
- 21 King J E, Dozois R R, Lindor N M. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc . 2000; 5 57-67
- 22 Chung D C. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology . 2000; 119 854-865
- 23 Corredor J, Wambach J, Barnard J. Gastrointestinal polyps in children: advances in molecular genetics, diagnosis, and management. J Pediatr . 2001; 138 621-628
- 24 Rozen P, Samuel Z, Shomrat R, Legum C. Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9. Gut . 1999; 45 829-833
- 25 Giardiello F M, Krush A J, Petersen G M. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology . 1994; 106 1542-1547
- 26 Olschwang S, Tiret A, Laurent-Puig P. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell . 1993; 75 959-968
- 27 Caspari R, Olschwang S, Friedl W. Familial adenomatous polyposis: desmoid tumors and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet . 1995; 4 337-340
- 28 Clark S K, Phillips R KS. Desmoids in familial adenomatous polyposis. Br J Surg . 1996; 83 1494-1504
- 29 Giardiello F M, Brensuinger J D, Luce M C. Phenotypic expression of disease in families that have mutations in the 5′ region of the adenomatous polyposis coli gene. Ann Intern Med . 1997; 126 514-519
- 30 Soravia C, Berk T, Madlensky L. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet . 1998; 62 1290-1301
- 31 Gayther S A, Wells D, SenGupta S B. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet . 1994; 3 53-56
- 32 Friedl W, Caspari R, Sengteller M. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis?. <~>Experience from 680 FAP families. Gut . 2001; 48 515-521
- 33 Lynch H T, Smyrk T, McGinn T. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer . 1995; 76 2427-2433
- 34 Traboulsi E I, Krush A J, Gardner E J. Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med . 1987; 316 661-667
- 35 Giardiello F M, Offerhaus G JA, Krush A J. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr . 1991; 119 766-768
- 36 Romania A, Zakov N, Church J, Jagelman D G. Retinal pigment epithelium lesions as a biomarker of disease in patients with familial adenomatous polyposis. Ophthalmology . 1992; 99 911-913
- 37 Hamilton S R, Liu B, Parson R E. The molecular basis of Turcot's syndrome. N Engl J Med . 1995; 332 839-847
- 38 Matsui T, Hayashi N, Yao K. A father and son with Turcot's syndrome: evidence for autosomal dominant inheritance: report of two cases. Dis Colon Rectum . 1998; 41 797-801
- 39 Goodman A A. Polypoid diseases. In: Corman ML, ed. Colon and Rectal Surgery Philadelphia, PA: Lippincott-Raven 1998: 607-616
- 40 Nivatvongs S. Benign neoplasms of the colon and rectum. In: Gordon PH, Nivatvongs S, eds. Principles and Practice of Surgery for the Colon, Rectum and Anus St. Louis, MO: Quality Medical 1999: 554-569
- 41 Winawer S J, Fletcher R H, Miller L. Colorectal cancer screeing: clinical guidelines and rationale (corrections in Gastroenterology 1997; 112:1060 and 1998;114:625). Gastroenterology . 1997; 112 594-642
- 42 Nugent K P, Phillips R KS. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern. Br J Surg . 1992; 79 1204-1206
- 43 Heiskanen I, Jarvinen H J. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Int J Colorect Dis . 1997; 12 9-13
- 44 Bess M A, Adson M A, Elveback L R, Moertal C G. Rectal cancer following colectomy for polyposis. Arch Surg . 1980; 115 460-467
- 45 Decosse J J, Bulow S, Neale K. Rectal cancer risk in patient treated for familial adenomatous polyposis. Br J Surg . 1992; 79 1372-1375
- 46 Wu J S, Paul P, McGannon E A, Church J M. APC genotype, polyp number, and surgical options in familial adenomatosis polyposis. Ann Surg . 1998; 227 57-62
- 47 Bertario L, Russo A, Radice P. Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Ann Surg . 2000; 231 538-543
- 48 Duijvendijk P V, Slors J FM, Taat C W. Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis. Ann Surg . 1999; 230 648-654
- 49 Nyam D C, Brillant P T, Dozois R R. Ileal pouch-anal canal anastomosis for familial adenomatous polyposis: early and late results. Ann Surg . 1997; 226 514-521
- 50 Penna C, Tiret E, Daude F, Parc R. Results of ileal pouch-anal anastomosis in familial adenomatous polyposis complicated by rectal carcinoma. Dis Colon Rectum . 1994; 37 157-160
- 51 Ambroze W L, Dozois R R, Pemberton J H. Familial adenomatous polyposis: results following ileal pouch-anal anastomosis and ileorectostomy. Dis Colon Rectum . 1992; 35 12-15
- 52 Kartheuser A H, Parc R, Penna C P. Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten year experience. Surgery . 1996; 119 615-623
- 53 Hoehner J C, Metcalf A M. Development of an invasive adenocarcinoma following colectomy with ileoanal anastomosis for familial polyposis coli: report of a case. Dis Colon Rectum . 1994; 37 824-828
- 54 Malassagne B, Penna C, Parc R. Adenomatous polyps in the anal transition zone after ileal pouch-anal anastomosis for familial adenomatous polyposis: treatment by transanal mucosectomy and ileal pouch advancement. B J Surg . 1995; 82 1634
- 55 Ziv Y, Church J M, Oakley J R. Surgery for the teenager with familial adenomatous polyposis: ileal-rectal anastomosis or restorative proctocolectomy?. Int J Colorect Dis . 1995; 10 6-9
- 56 Setti-Carraro P, Nicholls R J. Choice of prophylactic surgery for the large bowel component of familial adenomatous polyposis. Br J Surg . 1996; 83 885-892
- 57 Slors J FM, Ponson A E, Taat C W, Bosma A. Risk of residual rectal mucosa after proctocolectomy and ileal pouch-anal reconstruction with the double-stapling technique. Postoperative endoscopic follow-up study. Dis Colon Rectum . 1995; 38 207-210
- 58 Gemlo B T, Belmonte C, Wiltz O, Madoff R D. Functional assessment of ileal pouch-anal anastomotic techniques. Am J Surg . 1995; 169 137-142
- 59 Seow-Choen A T, Nicholls R J. Prospective randomized trial comparing anal function after hand sewn ileoanal anastomosis with mucosectomy versus stapled ileoanal anastomosis without mucosectomy in restorative proctocolectomy. Br J Surg . 1991; 78 430-434
- 60 Luukkonen P, Jarvinen H. Stapled versus hand-sutured ileoanal anastomosis in restorative proctocolectomy. Arch Surg . 1993; 128 437-440
- 61 Park J G, Park K Y, Ahn Y o. Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum . 1992; 35 996-998
- 62 Wallace M H, Phillips R KS. Preventative strategies for periampullary tumors in FAP. Ann Oncol . 1999; 10 S201-S203
- 63 Heiskanen I, Kellokumpu I, Jarvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy . 1999; 31 412-416
- 64 Offerhaus G JA, Giardiello F M, Krush A J. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology . 1992; 102 1980-1982
- 65 Milkvy P. Photodynamic therapy for polyposis in familial adenomatous polyposis. Eur J Cancer . 1995; 31A 1160-1165
- 66 Penna C, Phillips R KS, Tiret E, Spigelman A D. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg . 1993; 80 1027-1029
- 67 Penna C, Bataille N, Balladur P. Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis. Br J Surg . 1998; 85 665-668
- 68 Soravia C, Berk T, Haber G. Management of advanced duodenal polyposis in familial adenomatous polyposis. J Gastrointest Surg . 1997; 1 474-478
- 69 Gurbuz A K, Giardiello F M, Petersen G M. Desmoid tumours in familial adenomatous polyposis. Gut . 1994; 35 377-381
- 70 Lofti A M, Dozois R R, Gordon H. Mesenteric fibromatosis complicating familial adenomatosis polyposis: predisposing factors and results of treatment. Int J Colorectal Dis . 1989; 4 30-36
- 71 Penna C, Tiret E, Parc R. Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gyn Obstet . 1993; 177 263-268
- 72 Rodriguez-Bigas M A, Mahoney M C, Karakousis C P, Petrelli N J. Desmoid tumors in patients with familial adenomatous polyposis. Cancer . 1994; 74 1270-1274
- 73 Berk T, Cohen Z, McLeod R S, Stern H. Management of mesenteric desmoid tumours in familial adenomatous polyposis. Can J Surg . 1992; 35 393-395
- 74 Chatzipetrou M A, Tzakis A G, Pinna A D. Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatosis polyposis. Surgery . 2001; 129 277-281
- 75 Giardiello F M, Hamilton S R, Krush A J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med . 1993; 328 1313-1316
- 76 Steinbach G, Lynch P M, Phillips R KS. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med . 2000; 342 1946-1952
- 77 Niv Y, Fraser G M. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology . 1994; 107 854-857
- 78 Richard C S, Berk T, Bapat B V. Sulindac for periampullary polyps in FAP patients. Int J Colorect Dis . 1997; 12 14-18
- 79 Bapat B, Noorani H, Cohen Z. Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut . 1999; 44 698-703
- 80 Berk T, Cohen Z, Bapat B, Gallinger S. Negative genetic test result in familial adenomatous polyposis. Clinical screening implications. Dis Colon Rectum . 1999; 42 307-312
- 81 Vasen H FA, Griffioen G, Offerhaus G JA. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in the Netherlands. Dis Colon Rectum . 1990; 33 227-230